Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Early-Onset Hemophagocytic Lymphohistiocytosis and Inflammatory Neurotoxicity Prior to Post-transplant Cyclophosphamide: A Report of Two Cases.
Journal: Cureus
Published: July 14, 2026
A Phase 1b Study of Efmarodocokin Alfa, an Interleukin-22 Agonist, in Combination with Standard of Care, in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: March 27, 2026
System-level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated With High One-year Survival and Reduced Cost.
Journal: Transplantation and cellular therapy
Published: March 12, 2026
Targeting CD162 for Life-Threatening Cutaneous Chronic Graft-Versus-Host Disease: A Case Report.
Journal: EJHaem
Published: March 12, 2026
Pretreatment physical function as a risk factor for movement and neurocognitive treatment-emergent events (MNTs) in multiple myeloma (MM) patients treated with cilta-cel.
Journal: Journal of the neurological sciences
Published: December 11, 2025
Analysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patients.
Journal: Leukemia & lymphoma
Published: November 13, 2025
ICANS and mortality after CAR-T therapy for NHL patients can be predicted using physical function measures of falls, balance and strength deficits, and use of an assistive device.
Journal: Bone marrow transplantation
Published: May 19, 2025
Haploidentical Bone Marrow Transplantation for Sickle Cell Disease.
Journal: NEJM evidence
Published: February 25, 2025
Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and Donors.
Journal: Transplantation and cellular therapy
Published: February 21, 2024
Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant.
Journal: Haematologica
Published: July 22, 2022
Short-Term Storage of Mobilized Peripheral Blood Stem Cells in a Closed System Changes the Microenvironment and May Affect the Quantity of CD34+ and CD34+CD38-CD45RA-CD90+ Cells.
Journal: Transplantation and cellular therapy
Published: July 09, 2022
Replicated Risk Index of Patient Functional Status Prior to Allogeneic Hematopoietic Cell Transplantation Predicts Healthcare Utilization and Survival.
Journal: Transplantation and cellular therapy
Published: May 14, 2021
Last Updated: 09/26/2026